Abstract
Wnt signaling plays an essential role during development, but is also activated in diseases as diverse as neurodegeneration, osteoporosis, and cancer. Accumulating evidence demonstrates that Wnt signaling is also activated during cardiac remodeling and heart failure. In this chapter, we will provide a brief overview of Wnt signaling in all its complexity. Then we will discuss the evidence for its involvement in the development of cardiac hypertrophy, the wound healing after myocardial infarction (MI) and heart failure. Finally, we will provide an overview of the drugs that are available to target Wnt signaling at different levels of the signaling cascade and the results of these pharmacological interventions in cardiac disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aisagbonhi O, Rai M, Ryzhov S, Atria N, Feoktistov I, Hatzopoulos AK (2011) Experimental myocardial infarction triggers canonical Wnt signaling and endothelial-to-mesenchymal transition. Dis Model Mech 4(4):469–483
Anastas JN, Moon RT (2013) WNT signalling pathways as therapeutic targets in cancer. Nat Rev Cancer 13(1):11–26
Antos CL, McKinsey TA, Frey N, Kutschke W, McAnally J, Shelton JM et al (2002) Activated glycogen synthase-3 beta suppresses cardiac hypertrophy in vivo. Proc Natl Acad Sci U S A 99(2):907–912
Askevold ET, Aukrust P, Nymo SH, Lunde IG, Kaasboll OJ, Aakhus S et al (2014) The cardiokine secreted Frizzled-related protein 3, a modulator of Wnt signalling, in clinical and experimental heart failure. J Intern Med 275(6):621–630
Barandon L, Couffinhal T, Ezan J, Dufourcq P, Costet P, Alzieu P et al (2003) Reduction of infarct size and prevention of cardiac rupture in transgenic mice overexpressing FrzA. Circulation 108(18):2282–2289
Barandon L, Casassus F, Leroux L, Moreau C, Allieres C, Lamaziere JM et al (2011) Secreted frizzled-related protein-1 improves postinfarction scar formation through a modulation of inflammatory response. Arterioscler Thromb Vasc Biol 31(11):e80–e87
Baurand A, Zelarayan L, Betney R, Gehrke C, Dunger S, Noack C et al (2007) Beta-catenin downregulation is required for adaptive cardiac remodeling. Circ Res 100(9):1353–1362
Blagodatski A, Poteryaev D, Katanaev VL (2014) Targeting the Wnt pathways for therapies. Mol Cell Ther 2:28
Blankesteijn WM, Hermans KC (2015) Wnt signaling in atherosclerosis. Eur J Pharmacol 763:122–130
Blankesteijn WM, Essers-Janssen YPG, Ulrich MMW, Smits JFM (1996) Increased expression of a homologue of Drosophila tissue polarity gene ‘frizzled’ in left ventricular hypertrophy in the rat, as determined by subtractive hybridization. J Mol Cell Cardiol 28:1187–1191
Blankesteijn WM, Essers-Janssen YP, Verluyten MJ, Daemen MJ, Smits JF (1997) A homologue of Drosophila tissue polarity gene frizzled is expressed in migrating myofibroblasts in the infarcted rat heart. Nat Med 3(5):541–544
Blankesteijn WM, van Gijn ME, Essers-Janssen YPG, Daemen MJAP, Smits JFM (2000) Beta-catenin, an inducer of uncontrolled cell proliferation and migration in malignancies, is localized in the cytoplasm of vascular endothelial cells during neovascularization after myocardial infarction. Am J Pathol 157:877–883
Blumenthal A, Ehlers S, Lauber J, Buer J, Lange C, Goldmann T et al (2006) The Wingless homolog WNT5A and its receptor Frizzled-5 regulate inflammatory responses of human mononuclear cells induced by microbial stimulation. Blood 108(3):965–973
Blyszczuk P, Muller-Edenborn B, Valenta T, Osto E, Stellato M, Behnke S et al (2016) Transforming growth factor-beta-dependent Wnt secretion controls myofibroblast formation and myocardial fibrosis progression in experimental autoimmune myocarditis. Eur Heart J. doi:10.1093/eurheartj/ehw116
Bond J, Sedmera D, Jourdan J, Zhang Y, Eisenberg CA, Eisenberg LM et al (2003) Wnt11 and Wnt7a are up-regulated in association with differentiation of cardiac conduction cells in vitro and in vivo. Dev Dyn 227(4):536–543
Brade T, Manner J, Kuhl M (2006) The role of Wnt signalling in cardiac development and tissue remodelling in the mature heart. Cardiovasc Res 72(2):198–209
Chen L, Wu Q, Guo F, Xia B, Zuo J (2004) Expression of Dishevelled-1 in wound healing after acute myocardial infarction: possible involvement in myofibroblast proliferation and migration. J Cell Mol Med 8(2):257–264
Cleutjens JPM, Blankesteijn WM, Daemen MJAP, Smits JFM (1999) The infarcted myocardium: simply dead tissue or a lively target for therapeutic interventions. Cardiovasc Res 44:232–241
Clevers H (2006) Wnt/beta-catenin signaling in development and disease. Cell 127(3):469–480
Daskalopoulos EP, Janssen BJ, Blankesteijn WM (2012) Myofibroblasts in the infarct area: concepts and challenges. Microsc Microanal 18(1):35–49
Daskalopoulos EP, Hermans KC, Janssen BJ, Matthijs BW (2013) Targeting the Wnt/frizzled signaling pathway after myocardial infarction: a new tool in the therapeutic toolbox? Trends Cardiovasc Med 23(4):121–127
Dejana E (2010) The role of wnt signaling in physiological and pathological angiogenesis. Circ Res 107(8):943–952
Duan J, Gherghe C, Liu D, Hamlett E, Srikantha L, Rodgers L et al (2012) Wnt1/betacatenin injury response activates the epicardium and cardiac fibroblasts to promote cardiac repair. EMBO J 31(2):429–442
Eisenberg CA, Gourdie RG, Eisenberg LM (1997) Wnt-11 is expressed in early avian mesoderm and required for the differentiation of the quail mesoderm cell line QCE-6. Development 124(2):525–536
Francis Stuart SD, De Jesus NM, Lindsey ML, Ripplinger CM (2016) The crossroads of inflammation, fibrosis, and arrhythmia following myocardial infarction. J Mol Cell Cardiol 91:114–122
Fujio Y, Matsuda T, Oshima Y, Maeda M, Mohri T, Ito T et al (2004) Signals through gp130 upregulate Wnt5a and contribute to cell adhesion in cardiac myocytes. FEBS Lett 573(1–3):202–206
Gurpinar E, Grizzle WE, Piazza GA (2014) NSAIDs inhibit tumorigenesis, but how? Clin Cancer Res 20(5):1104–1113
Hagenmueller M, Riffel JH, Bernhold E, Fan J, Zhang M, Ochs M et al (2013) Dapper-1 induces myocardial remodeling through activation of canonical Wnt signaling in cardiomyocytes. Hypertension 61(6):1177–1183
Hagenmueller M, Riffel JH, Bernhold E, Fan J, Katus HA, Hardt SE (2014) Dapper-1 is essential for Wnt5a induced cardiomyocyte hypertrophy by regulating the Wnt/PCP pathway. FEBS Lett 588(14):2230–2237
Hahn JY, Cho HJ, Bae JW, Yuk HS, Kim KI, Park KW et al (2006) Beta-catenin overexpression reduces myocardial infarct size through differential effects on cardiomyocytes and cardiac fibroblasts. J Biol Chem 281(41):30979–30989
Haq S, Choukroun G, Kang ZB, Ranu H, Matsui T, Rosenzweig A et al (2000) Glycogen synthase kinase-3beta is a negative regulator of cardiomyocyte hypertrophy. J Cell Biol 151:117–129
Haq S, Michael A, Andreucci M, Bhattacharya K, Dotto P, Walters B et al (2003) Stabilization of beta-catenin by a Wnt-independent mechanism regulates cardiomyocyte growth. Proc Natl Acad Sci U S A 100(8):4610–4615
He W, Zhang L, Ni A, Zhang Z, Mirotsou M, Mao L et al (2010) Exogenously administered secreted frizzled related protein 2 (Sfrp2) reduces fibrosis and improves cardiac function in a rat model of myocardial infarction. Proc Natl Acad Sci U S A 107(49):21110–21115
Hermans KC, Blankesteijn WM (2015) Wnt signaling in cardiac disease. Compr Physiol 5(3):1183–11209
Hermans KC, Daskalopoulos EP, Blankesteijn WM (2016) The Janus face of myofibroblasts in the remodeling heart. J Mol Cell Cardiol 91:35–41
Hou N, Ye B, Li X, Margulies KB, Xu H, Wang X, et al (2016) Transcription factor 7-like 2 mediates canonical Wnt/beta-catenin signaling and c-Myc upregulation in heart failure. Circ Heart Fail 9(6). pii:e003010. doi:10.1161/CIRCHEARTFAILURE.116.003010
Huisamen B, Hafver TL, Lumkwana D, Lochner A (2016) The impact of chronic glycogen synthase kinase-3 inhibition on remodeling of normal and Pre-diabetic Rat hearts. Cardiovasc Drugs Ther 30(3):237–246, Sponsored by the International Society of Cardiovascular Pharmacotherapy
Hurlstone AF, Haramis AP, Wienholds E, Begthel H, Korving J, Van Eeden F et al (2003) The Wnt/beta-catenin pathway regulates cardiac valve formation. Nature 425(6958):633–637
Janda CY, Garcia KC (2015) Wnt acylation and its functional implication in Wnt signalling regulation. Biochem Soc Trans 43(2):211–216
Janda CY, Waghray D, Levin AM, Thomas C, Garcia KC (2012) Structural basis of Wnt recognition by Frizzled. Science 337(6090):59–64
Jenei V, Sherwood V, Howlin J, Linnskog R, Safholm A, Axelsson L et al (2009) A t-butyloxycarbonyl-modified Wnt5a-derived hexapeptide functions as a potent antagonist of Wnt5a-dependent melanoma cell invasion. Proc Natl Acad Sci U S A 106(46):19473–19478
Jin X, Guo B, Yan J, Yang R, Chang L, Wang Y et al (2015) Angiotensin II increases secreted frizzled- elated protein 5 (sFRP5) expression through AT1 receptor/Rho/ROCK1/JNK signaling in cardiomyocytes. Mol Cell Biochem 408(1–2):215–222
Joiner DM, Ke J, Zhong Z, Xu HE, Williams BO (2013) LRP5 and LRP6 in development and disease. Trends Endocrinol Metab 24(1):31–39
Kobayashi K, Luo M, Zhang Y, Wilkes DC, Ge G, Grieskamp T et al (2009) Secreted Frizzled-related protein 2 is a procollagen C proteinase enhancer with a role in fibrosis associated with myocardial infarction. Nat Cell Biol 11(1):46–55
Kuhl M, Sheldahl LC, Park M, Miller JR, Moon RT (2000) The Wnt/Ca2+ pathway: a new vertebrate Wnt signaling pathway takes shape. Trends Genet 16:279–283
Laeremans H, Hackeng TM, van Zandvoort MA, Thijssen VL, Janssen BJ, Ottenheijm HC et al (2011) Blocking of frizzled signaling with a homologous peptide fragment of wnt3a/wnt5a reduces infarct expansion and prevents the development of heart failure after myocardial infarction. Circulation 124(15):1626–1635
Laflamme MA, Murry CE (2011) Heart regeneration. Nature 473(7347):326–335
Lal H, Ahmad F, Woodgett J, Force T (2015) The GSK-3 family as therapeutic target for myocardial diseases. Circ Res 116(1):138–149
Langton PF, Kakugawa S, Vincent JP (2016) Making, exporting, and modulating Wnts. Trends Cell Biol. doi:10.1016/j.tcb.2016.05.011
Libro R, Bramanti P, Mazzon E (2016) The role of the Wnt canonical signaling in neurodegenerative diseases. Life Sci 158:78–88
MacDonald BT, Tamai K, He X (2009) Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 17(1):9–26
Malekar P, Hagenmueller M, Anyanwu A, Buss S, Streit MR, Weiss CS et al (2010) Wnt signaling is critical for maladaptive cardiac hypertrophy and accelerates myocardial remodeling. Hypertension 55(4):939–945
Matsushima K, Suyama T, Takenaka C, Nishishita N, Ikeda K, Ikada Y et al (2010) Secreted frizzled related protein 4 reduces fibrosis scar size and ameliorates cardiac function after ischemic injury. Tissue Eng Part A 16(11):3329–3341
Maye P, Zheng J, Li L, Wu D (2004) Multiple mechanisms for Wnt11-mediated repression of the canonical Wnt signaling pathway. J Biol Chem 279(23):24659–24665
Min JK, Park H, Choi HJ, Kim Y, Pyun BJ, Agrawal V et al (2011) The WNT antagonist Dickkopf2 promotes angiogenesis in rodent and human endothelial cells. J Clin Invest 121(5):1882–1893
Mirotsou M, Zhang Z, Deb A, Zhang L, Gnecchi M, Noiseux N et al (2007) Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair. Proc Natl Acad Sci U S A 104(5):1643–1648
Mohamed TM, Abou-Leisa R, Stafford N, Maqsood A, Zi M, Prehar S et al (2016) The plasma membrane calcium ATPase 4 signalling in cardiac fibroblasts mediates cardiomyocyte hypertrophy. Nat Commun 7:11074
Morishita Y, Kobayashi K, Klyachko E, Jujo K, Maeda K, Losordo DW et al (2016) Wnt11 gene therapy with adeno-associated virus 9 improves recovery from myocardial infarction by modulating the inflammatory response. Sci Rep 6:21705
Motiwala SR, Szymonifka J, Belcher A, Weiner RB, Baggish AL, Gaggin HK et al (2014) Measurement of novel biomarkers to predict chronic heart failure outcomes and left ventricular remodeling. J Cardiovasc Transl Res 7(2):250–261
Murakoshi M, Saiki K, Urayama K, Sato TN (2013) An anthelmintic drug, pyrvinium pamoate, thwarts fibrosis and ameliorates myocardial contractile dysfunction in a mouse model of myocardial infarction. PLoS One 8(11), e79374
Mureli S, Gans CP, Bare DJ, Geenen DL, Kumar NM, Banach K (2013) Mesenchymal stem cells improve cardiac conduction by upregulation of connexin 43 through paracrine signaling. Am J Physiol Heart Circ Physiol 304(4):H600–H609
Nakamura K, Sano S, Fuster JJ, Kikuchi R, Shimizu I, Ohshima K et al (2016) Secreted frizzled-related protein 5 diminishes cardiac inflammation and protects the heart from ischemia/reperfusion injury. J Biol Chem 291(6):2566–2575
Oerlemans MI, Goumans MJ, van Middelaar B, Clevers H, Doevendans PA, Sluijter JP (2010) Active Wnt signaling in response to cardiac injury. Basic Res Cardiol 105(5):631–641
Oikonomopoulos A, Sereti KI, Conyers F, Bauer M, Liao A, Guan J et al (2011) Wnt signaling exerts an antiproliferative effect on adult cardiac progenitor cells through IGFBP3. Circ Res 109(12):1363–1374
Opie LH, Commerford PJ, Gersh BJ, Pfeffer MA (2006) Controversies in ventricular remodelling. Lancet 367(9507):356–367
Pahnke A, Conant G, Huyer LD, Zhao Y, Feric N, Radisic M (2016) The role of Wnt regulation in heart development, cardiac repair and disease: a tissue engineering perspective. Biochem Biophys Res Commun 473(3):698–703
Paik DT, Rai M, Ryzhov S, Sanders LN, Aisagbonhi O, Funke MJ et al (2015) Wnt10b gain-of-function improves cardiac repair by arteriole formation and attenuation of fibrosis. Circ Res 117(9):804–816
Pandur P, Lasche M, Eisenberg LM, Kuhl M (2002) Wnt-11 activation of a non-canonical Wnt signalling pathway is required for cardiogenesis. Nature 418(6898):636–641
Pereira C, Schaer DJ, Bachli EB, Kurrer MO, Schoedon G (2008) Wnt5A/CaMKII signaling contributes to the inflammatory response of macrophages and is a target for the antiinflammatory action of activated protein C and interleukin-10. Arterioscler Thromb Vasc Biol 28(3):504–510
Qu J, Zhou J, Yi XP, Dong B, Zheng H, Miller LM et al (2007) Cardiac-specific haploinsufficiency of beta-catenin attenuates cardiac hypertrophy but enhances fetal gene expression in response to aortic constriction. J Mol Cell Cardiol 43(3):319–326
Radice GL, Rayburn H, Matsunami H, Knudsen KA, Takeichi M, Hynes RO (1997) Developmental defects in mouse embryos lacking N-cadherin. Dev Biol 181(1):64–78
Riffell JL, Lord CJ, Ashworth A (2012) Tankyrase-targeted therapeutics: expanding opportunities in the PARP family. Nat Rev Drug Discov 11(12):923–936
Rohini A, Agrawal N, Koyani CN, Singh R (2010) Molecular targets and regulators of cardiac hypertrophy. Pharmacol Res 61(4):269–280
Safholm A, Leandersson K, Dejmek J, Nielsen CK, Villoutreix BO, Andersson T (2006) A formylated hexapeptide ligand mimics the ability of Wnt-5a to impair migration of human breast epithelial cells. J Biol Chem 281(5):2740–2749
Saraswati S, Alfaro MP, Thorne CA, Atkinson J, Lee E, Young PP (2010) Pyrvinium, a potent small molecule Wnt inhibitor, promotes wound repair and post-MI cardiac remodeling. PLoS One 5(11), e15521
Sasaki T, Hwang H, Nguyen C, Kloner RA, Kahn M (2013) The small molecule Wnt signaling modulator ICG-001 improves contractile function in chronically infarcted rat myocardium. PLoS One 8(9), e75010
Schulte G, Bryja V (2007) The Frizzled family of unconventional G-protein-coupled receptors. Trends Pharmacol Sci 28(10):518–525
Schumann H, Holtz J, Zerkowski HR, Hatzfeld M (2000) Expression of secreted frizzled related proteins 3 and 4 in human ventricular myocardium correlates with apoptosis related gene expression. Cardiovasc Res 45(3):720–728
Simons M, Mlodzik M (2008) Planar cell polarity signaling: from fly development to human disease. Annu Rev Genet 42:517–540
Sklepkiewicz P, Shiomi T, Kaur R, Sun J, Kwon S, Mercer B et al (2015) Loss of secreted frizzled-related protein-1 leads to deterioration of cardiac function in mice and plays a role in human cardiomyopathy. Circ Heart Fail 8(2):362–372
Staal FJ, Luis TC, Tiemessen MM (2008) WNT signalling in the immune system: WNT is spreading its wings. Nat Rev Immunol 8(8):581–593
Sugden PH, Fuller SJ, Weiss SC, Clerk A (2008) Glycogen synthase kinase 3 (GSK3) in the heart: a point of integration in hypertrophic signalling and a therapeutic target? A critical analysis. Br J Pharmacol 153(Suppl 1):S137–S153
Tao J, Wang YT, Abudoukelimu M, Yang YN, Li XM, Xie X, et al (2016) Association of genetic variations in the Wnt signaling pathway genes with myocardial infarction susceptibility in Chinese Han population. Oncotarget. doi:10.18632/oncotarget.10401
Tateishi A, Matsushita M, Asai T, Masuda Z, Kuriyama M, Kanki K et al (2010) Effect of inhibition of glycogen synthase kinase-3 on cardiac hypertrophy during acute pressure overload. Gen Thorac Cardiovasc Surg 58(6):265–270
Timmers L, Sluijter JP, van Keulen JK, Hoefer IE, Nederhoff MG, Goumans MJ et al (2008) Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction. Circ Res 102(2):257–264
Toyofuku T, Hong Z, Kuzuya T, Tada M, Hori M (2000) Wnt/Frizzled-2 signaling induces aggregation and adhesion among cardiac myocytes by increased cadherin-beta-catenin complex. J Cell Biol 150(1):225–241
Tseng AS, Engel FB, Keating MT (2006) The GSK-3 inhibitor BIO promotes proliferation in mammalian cardiomyocytes. Chem Biol 13(9):957–963
Uitterdijk A, Hermans KC, de Wijs-Meijler DP, Daskalopoulos EP, Reiss IK, Duncker DJ et al (2016) UM206, a selective Frizzled antagonist, attenuates adverse remodeling after myocardial infarction in swine. Lab Invest 96(2):168–176
van de Schans VA, van den Borne SW, Strzelecka AE, Janssen BJ, van der Velden JL, Langen RC et al (2007) Interruption of Wnt signaling attenuates the onset of pressure overload-induced cardiac hypertrophy. Hypertension 49(3):473–480
van den Borne SW, Diez J, Blankesteijn WM, Verjans J, Hofstra L, Narula J (2010) Myocardial remodeling after infarction: the role of myofibroblasts. Nat Rev Cardiol 7(1):30–37
Wang H, Hao J, Hong CC (2011) Cardiac induction of embryonic stem cells by a small molecule inhibitor of Wnt/beta-catenin signaling. ACS Chem Biol 6(2):192–197
Weidinger G, Moon RT (2003) When Wnts antagonize Wnts. J Cell Biol 162(5):753–755
Weng Z, Kong CW, Ren L, Karakikes I, Geng L, He J et al (2014) A simple, cost-effective but highly efficient system for deriving ventricular cardiomyocytes from human pluripotent stem cells. Stem Cells Dev 23(14):1704–1716
Woulfe KC, Gao E, Lal H, Harris D, Fan Q, Vagnozzi R et al (2010) Glycogen synthase kinase-3beta regulates post-myocardial infarction remodeling and stress-induced cardiomyocyte proliferation in vivo. Circ Res 106(10):1635–1645
Zelarayan LC, Noack C, Sekkali B, Kmecova J, Gehrke C, Renger A et al (2008) Beta-catenin downregulation attenuates ischemic cardiac remodeling through enhanced resident precursor cell differentiation. Proc Natl Acad Sci U S A 105(50):19762–19767
Zhang X, Hao J (2015) Development of anticancer agents targeting the Wnt/beta-catenin signaling. Am J Cancer Res 5(8):2344–2360
Zhang CG, Jia ZQ, Li BH, Zhang H, Liu YN, Chen P et al (2009) beta-Catenin/TCF/LEF1 can directly regulate phenylephrine-induced cell hypertrophy and Anf transcription in cardiomyocytes. Biochem Biophys Res Commun 390(2):258–262
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Stylianidis, V., Hermans, K.C.M., Blankesteijn, W.M. (2016). Wnt Signaling in Cardiac Remodeling and Heart Failure. In: Bauersachs, J., Butler, J., Sandner, P. (eds) Heart Failure. Handbook of Experimental Pharmacology, vol 243. Springer, Cham. https://doi.org/10.1007/164_2016_56
Download citation
DOI: https://doi.org/10.1007/164_2016_56
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-59658-7
Online ISBN: 978-3-319-59659-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)